Browse:Home / Pfizer CEO says Omicron variant targeted vaccine is most likely outcome
Pfizer CEO says Omicron variant targeted vaccine is most likely outcome
Pfizer Inc (PFE.N) Chief Executive Albert Bourla said on Monday that moving toward a redesigned COVID-19 vaccine that is specifically targeted to combat the Omicron variant of the coronavirus is the “most likely scenario.”